Physician profile
Edward B Aull
NPI 1922009786
$20,005.74
in general payments reported to CMS, 2019-2025
14 companies · $376 in 2025
The $376 reported for 2025 was more than what 81% of Developmental - Behavioral Pediatrics providers received nationally (typical 2025 total: $79.84).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $971 · 2021: $17K · 2022: $381 · 2023: $488 · 2024: $344 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Education: $74.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.76 |
| Education | $74.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $18,212.96 | 2020-2025 | Qelbree, Qelbree |
| Jazz Pharmaceuticals INC. | $463.77 | 2019-2024 | Xywav |
| Corium, LLC | $321.41 | 2021-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $316.94 | 2019-2023 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $230.67 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $106.00 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $96.08 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.33 | 2019-2021 | |
| Shire North American Group INC | $45.23 | 2019 | |
| Sanofi Pasteur INC. | $39.15 | 2019 | |
| Neos Therapeutics, Lp | $39.04 | 2019-2021 | |
| Rhodes Pharmaceuticals L.P. | $21.64 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.38 | 2019 | |
| Harmony Biosciences LLC | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Aull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.